Article Details
Retrieved on: 2020-08-07 00:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>CytoDyn <b>Inc</b> (OTCQB:CYDY), which is developing leronlimab (PRO 140) to battle multiple diseases, said Friday that it will submit requests for pre- ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here